Psychiatry and Clinical Psychopharmacology
Research Abstracts

Methylphenidate Increases cGMP Levels in Rat Brain

1.

Gulhane Military Medical School, Department of Child and Adolescent Psychiatry, Ankara-Turkey

2.

Gölcük Military Naval Hospital, Department of Child and Adolescent Psychiatry, İzmit-Turkey

3.

Gülhane Military Medical School, Ankara-Turkey

4.

Gulhane Military Medical School, Department of Toxicology, Ankara-Turkey

Psychiatry and Clinical Psychopharmacology 2005; 15: 1-4
Read: 646 Downloads: 444 Published: 05 March 2021

Objective: Methylphenidate (MPH) is commonly and effectively used to treat children and adolescents with attention-deficit hyperactivity disorder. However, MPH still poses a number of questions on which mechanisms of effect it has on the brain. The present study addresses the question of whether MPH induces cyclic guanosine 3',5’-monophosphate (cGMP) in rat brain.

Methods: MPH at a dose of 10mg /kg p.o. was administered to rats daily for 8 weeks, whereas control rats were given distilled water. The level of cGMP was measured in total brains of the rats.

Results: Brain cGMP levels were higher in the study group when compared with the control group (p=0.004).

Conclusions: Our results suggested that the long term MPH administration might increase cGMP activity in rat brain.

Files
EISSN 2475-0581